UTMD — Utah Medical Products Balance Sheet
0.000.00%
- $190.55m
- $108.37m
- $40.90m
- 96
- 65
- 49
- 81
Annual balance sheet for Utah Medical Products, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 51.6 | 61 | 75.1 | 92.9 | 83 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4.1 | 5.13 | 5.54 | 3.39 | 4.09 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 62.3 | 73.2 | 89.9 | 106 | 96.3 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 11.3 | 11.1 | 10.2 | 10.6 | 9.76 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Total Assets | 112 | 116 | 124 | 135 | 123 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.79 | 3.75 | 5.96 | 4.71 | 3.76 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 8.92 | 8.5 | 9.62 | 7.14 | 5.11 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 103 | 107 | 114 | 128 | 117 |
| Total Liabilities & Shareholders' Equity | 112 | 116 | 124 | 135 | 123 |
| Total Common Shares Outstanding |